MedPath

ong Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation

Phase 3
Completed
Conditions
Health Condition 1: null- Cyanotic congenital heart disease palliated with a systemic-to-pulmonary artery shunt and the shunt is still in place at one year of age.Health Condition 2: Q257- Other congenital malformations ofpulmonary artery
Registration Number
CTRI/2009/091/000909
Lead Sponsor
SanofiSynthelabo India Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
47
Inclusion Criteria

Patients randomized in the CLARINET study who still are receiving the study drug and with the palliative systemic-to-pulmonary artery shunt still in place at 1 year of age, − for whom the investigator?s decision is to continue the study drug treatment based on his/her judgment of the expected benefit/risk of continuing treatment with study drug.

Exclusion Criteria

Patients who have had primary efficacy endpoint ( Shunt thrombosis and early cardiac related procedure of thrombotic nature) during the Clarient study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main endpoint will be safety as evaluated by the incidence of adverse events and serious <br/ ><br>adverse events including bleeding. <br/ ><br>Assessment of clinical safety will rely on recording of all adverse events whatever the seriousness <br/ ><br>including bleeding reported by the investigator during the protocol planned visits or unscheduled <br/ ><br>contacts established with the investigator by the patient?s parents or his/her primary care <br/ ><br>physician. <br/ ><br>Timepoint: Day 01 ( Randomization ) , 3 month , 6 month <br/ ><br> Telephonic calls at 1st , 2nd , 4th , 5th Month <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
The secondary endpoint will be the efficacy assessed by the occurrence of shunt thrombosis <br/ ><br>requiring intervention or any death. <br/ ><br>Timepoint: Day 01 ( Randomization ) , 3 month , 6 month <br/ ><br> Telephonic calls at 1st , 2nd , 4th , 5th Month <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath